1. Contractors
  2. Chrysalis Biotherapeutics, Inc.

Chrysalis Biotherapeutics, Inc.

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Chrysalis Biotherapeutics has 1 federal contract of $100,000 or more active since October 2023, with $13M obligated, from 1 agency. None is running now.

Contracts
1 since FY2024$13,030,326 obligated, contracts of $100,000 or more
Running now
None
Biggest customer
Office of Assistant Secretary for Preparedness and Response$13M on 1 contract
UEI
XW1VFGGRLDW3Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

No contract of $100,000 or more is running now.

Who they work for

AgencyAmount
Office of Assistant Secretary for Preparedness and Response1 contract$13,030,326

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract$13,030,326

Where the work is

Place of workAmount
Texas1 contract$13,030,326

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.

Get new notices like Chrysalis Biotherapeutics's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy